Based on SEC filing data. A biotech corporation based in San Carlos, CA raised $6.5M in Series B funding through a convertible note. The company is at the growth stage of development.
Get notified the moment Cellerant Therapeutics Inc files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.